FIELD: organic chemistry, medicine, pharmacy.
SUBSTANCE: invention relates to new biologically active derivatives of dihydrobenzo[b][1,4]diazepine-2-one. Invention describes derivatives of dihydrobenzo[b][1,4]diazepine-2-one of the general formula (I): wherein X means a simple bond or ethynediyl group wherein if X means a simple bond then R1 means cyano-group, halogen atom, lower alkyl, (C1-C3)-cycloalkyl, (lower)-alkoxyl, fluoro-(lower)-alkyl or it means pyrrole-1-yl that may be free or substituted with 1-3 substitutes taken among the group consisting of fluorine, chlorine atom, cyano-group, -(CH2)1-4-hydroxyl group, fluoro-(lower)-alkyl, lower alkyl, -(CH2)n-(lower)-alkoxyl, -(CH2)n-C(O)OR'', -(CH2)1-4-NR'R'', hydroxy-(lower)-alkoxyl and -(CH2)n-COR'R'', or it means free phenyl or phenyl substituted with one or two substitutes taken among the group consisting of halogen atom, lower alkyl, fluoro-(lower)-alkyl, (lower)-alkoxyl, fluoro-(lower)-alkoxyl and cyano-group; if X means ethynediyl group then R1 means free phenyl or phenyl substituted with 1-3 substituted taken among the group consisting of halogen atom, lower alkyl, fluoro-(lower)-alkyl, (C3-C6)-cycloalkyl, (lower)-alkoxyl and fluoro-(lower)-alkoxyl; R2 means -NR'R'', fluoro-(lower)-alkoxyl or 3-oxopiperazin-1-yl, pyrrolidin-1-yl, or piperidin-1-yl wherein their rings are substituted optionally with R''; R' means hydrogen atom, lower alkyl, (C3-C6)-cycloalkyl, fluoro-(lower)-alkyl or 2-(lower)-alkoxy-(lower)-alkyl; R'' means hydrogen atom, lower alkyl, (C3-C6)-cycloalkyl, fluoro-(lower)-alkyl, 2-(lower)-alkoxy-(lower)-alkyl, -(CH2)2-4-di-(lower)-alkylamino-group, -(CH2)2-4-morpholinyl, -(CH2)2-4-pyrrolidinyl, -(CH2)2-4-piperidinyl or 3-hydroxy-(lower)-alkyl; Y means -CH= or =N-; R3 means halogen atom, lower alkyl, fluoro-(lower)-alkyl, (lower)-alkoxyl, cyano-group, -(CH2)n-C(O)OR'', -(CH2)1-4-NR'R'' or it means optionally substituted 5-membered aromatic heterocycle that can be substituted with halogen atom, fluoro-(lower)-alkyl, fluoro-(lower)-alkoxyl, cyano-group, -(CH2)n-NR'R'', -(CH2)n-C(O)OR'', -(CH2)n-C(O)NR'R'', -(CH2)n-SO2NR'R'', -(CH2)n-C(NH2)=NR'', hydroxyl, (lower)-alkoxyl, (lower)-alkylthio-group or lower alkyl that is optionally substituted with fluorine atom, hydroxyl, (lower)-alkoxyl, cyano-group or carbamoyloxy-group; n means 0, 1, 2, 3 or 4, and their pharmaceutically acceptable additive salts. Also, invention describes a medicinal agent as antagonist of mGlu receptors of group II based on compounds of the formula (I). Invention provides preparing new compounds eliciting valuable biological properties.
EFFECT: valuable medicinal properties of compounds.
17 cl, 496 ex
Title | Year | Author | Number |
---|---|---|---|
DERIVATIVES OF DIHYDROBENZO[b][1,4]DIAZEPINE-2-ONE AS I mGluR2 ANTAGONISTS | 2002 |
|
RU2270197C2 |
DERIVATIVES OF DIHYDROBENZODIAZEPIN-2-ONE FOR TREATMENT OF NEUROLOGICAL DISORDERS | 2003 |
|
RU2315764C2 |
DERIVATIVES OF BENZODIAZEPINE AND MEDICINAL AGENT COMPRISING THEREOF | 2000 |
|
RU2259360C2 |
DERIVATIVES OF BENZODIAZEPINE, MEDICINAL AGENT COMPRISING THEREOF AND METHOD FOR THEIR PREPARING | 2000 |
|
RU2257382C2 |
DERIVATIVES OF CARBAMIC ACID ESTERS, THEIR PREPARING (VARIANTS) AND THEIR APPLYING AS LIGANDS OF METABOTROPIC GLUTAMATE RECEPTORS | 2000 |
|
RU2248349C2 |
BENZOTHIAZOLE DERIVATIVES | 2001 |
|
RU2251419C2 |
DERIVATIVES OF BENZIMIDAZOL INHIBITING FACTOR Xa | 2004 |
|
RU2346944C2 |
DERIVATIVES OF 1,2,4,5-TETRAHYDROBENZO[D]AZEPINES AND MEDICINAL AGENT BASED ON THEREOF | 2000 |
|
RU2240317C2 |
DERIVATIVES OF 4-PYRROLIDINE PHENYL BENZOLE ETHER | 2003 |
|
RU2336268C2 |
DERIVATIVES OF BENZODIAZEPINE AND PHARMACEUTICAL COMPOSITION BASED ON THEREOF | 2001 |
|
RU2278865C2 |
Authors
Dates
2005-10-27—Published
2002-04-02—Filed